Ocugen has announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to ...

In a study of 10 patients, the LYNX LIO achieved a mean treatment time of 16 minutes, 43 seconds, with 3,489 spots delivered ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Advanced autofluorescence reveals cellular pigment reservoirs with therapeutic potential at the Heidelberg 2025 International ...

NASA’s development of autonomous eye imaging technologies for astronauts aboard the International Space Station is paving the ...

Funding will support the continued clinical advancement of its lead ocular implant candidate, PA5108, for the reduction of ...

The rationale for the study under discussion is that the experience level of the operating surgeon is a potential factor ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

EssilorLuxottica and MidEuropa recently entered into an agreement that will allow EssilorLuxottica to acquire Optegra, ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A panelist discusses how treating ocular surface disease and demodex blepharitis before cataract surgery led to improved refractive measurements, resolved corneal staining, and enabled successful ...